I dunno. I actually decided to start accumulating shares at the ridiculously slow rate of 1000/wk. One would think that with their pipeline and all the analyst coverage there would be more interest.
[Edit]
PS: Despite being a published virologist this marks my first entry into a company focusing on antivirals. So I'm fairly impressed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.